Dosage & Administration Biomarker testing Drug label Prior authorization Pharmacy Financial assistance

Herceptin hylecta

(hyaluronidase / trastuzumab)

Herceptin Hylecta 600 MG / 10,000 UNT in 5 mL Injection

Dosage & administration

For subcutaneous use only. HERCEPTIN HYLECTA has different dosage and administration instructions than intravenous trastuzumab products.

Do not administer intravenously.

Do not substitute HERCEPTIN HYLECTA for or with ado-trastuzumab emtansine.

Perform HER2 testing using FDA-approved tests by laboratories with demonstrated proficiency.

The recommended dose of HERCEPTIN HYLECTA is 600 mg/10,000 units (600 mg trastuzumab and 10,000 units hyaluronidase) administered subcutaneously over approximately 2-5 minutes once every three weeks.

biomarker testing

Herceptin hylecta clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Herceptin hylecta prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Herceptin hylecta prior authorization resources

Most recent Herceptin hylecta prior authorization forms

View By Payer

Updated: May 31, 2023Cigna - Herceptin Hylecta Prior Authorization Form

Updated: May 24, 2023Aetna - Herceptin Hylecta Prior Authorization Form

Updated: May 23, 2023Aetna - Medicare Part B Herceptin/Herceptin Hylecta Prior Authorization Form

OTHERComplete Letter of Medical Necessity

OTHERCoverage Authorization Appeals

PDFPatient Consent Form

PDFPatient Consent Form - Spanish

Learn More

Benefits investigation

PDFHerceptin Hylecta Prescriber Service & Patient Consent Form

Herceptin Hylecta Prescriber Service Form - Online Portal

Learn More

pharmacy

Herceptin hylecta preferred pharmacy

OTHERPharmacy List

financial assistance

Herceptin hylecta financial assistance options

Co-pay savings program

commercial only

PDFHerceptin Hylecta Prescriber Service & Patient Consent Form

Herceptin Hylecta Prescriber Service Form - Online Portal

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFHerceptin Hylecta Prescriber Service & Patient Consent Form

Herceptin Hylecta Prescriber Service Form - Online Portal

PDFGenentech Patient Foundation Application Form (1/2)

PDFGenentech Patient Foundation Application Form (2/2) - Patient Consent Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Herceptin hylecta patient education

Getting started on Herceptin hylecta

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Learn More

Other resources

Learn More

Herceptin hylecta FAQs

How is the dosage of Herceptin hylecta?Herceptin Hylecta is available in 1 dosages, including 10,000-600 var units/5ml Injection 5 ml

What does Herceptin hylecta treat?Herceptin Hylecta treats Breast Neoplasms, Extravasation of Diagnostic and Therapeutic Materials and Gastrointestinal Neoplasms

What is Herceptin hylecta made of?Herceptin Hylecta contains hyaluronidase / trastuzumab which is a HER2/neu Receptor Antagonist

How Is Herceptin hylecta Administered?Herceptin Hylecta is administered as a Injectable

What Are The Herceptin hylecta Mechanism Of Action?Herceptin Hylecta mechanism of action is HER2/Neu/cerbB2 Antagonists

FAQ Data Source

Herceptin hylecta

Dosage & administration

biomarker testing

Herceptin hylecta clinical details

drug label

Herceptin hylecta prescribing information

prior authorization

Herceptin hylecta prior authorization resources

Most recent Herceptin hylecta prior authorization forms

Benefits investigation

pharmacy

Herceptin hylecta preferred pharmacy

financial assistance

Herceptin hylecta financial assistance options

Co-pay savings program

Foundation programs

patient education

Herceptin hylecta patient education

Getting started on Herceptin hylecta

Patient toolkit

Other resources

people also ask

Herceptin hylecta FAQs